Special Issue “Host Targeted Therapeutics Against Virus Infections”
Viruses · 25.11.2024 · 16 (12) · 1825
DOI: 10.3390/v16121825 ↗Kurz gefasst
Editorial in der Zeitschrift Viruses, online erschienen am 25.11.2024. Verfasst von Stephan Pleschka. Beteiligte Einrichtung: Institute of Medical Virology, Justus Liebig University Giessen, 35392 Giessen, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic, along with the emergence and sustained transmission of highly pathogenic avian influenza viruses (H5N1) in U [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Medical Virology, Justus Liebig University Giessen, 35392 Giessen, Germany.
- German Center for Infection Research (DZIF), Partner Site Giessen, 35392 Giessen, Germany.
ORCID-Profile: Stephan Pleschka
Zitieren
APA
Pleschka, S. (2024). Special Issue “Host Targeted Therapeutics Against Virus Infections”. Viruses, 16(12), 1825. https://doi.org/10.3390/v16121825
Vancouver
Pleschka S. Special Issue “Host Targeted Therapeutics Against Virus Infections”. Viruses. 2024;16(12):1825. doi:10.3390/v16121825
BibTeX
@article{Pleschka2024,
author = {Pleschka, Stephan},
title = {Special Issue “Host Targeted Therapeutics Against Virus Infections”},
journal = {Viruses},
year = {2024},
volume = {16},
number = {12},
pages = {1825},
doi = {10.3390/v16121825}
}
EUVIMED